Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker

Prostate cancer is responsible for hundreds of thousands of annual deaths worldwide. The current gold standard in early detection of prostate cancer, the prostate specific antigen test, boasts a high sensitivity but low specificity, resulting in many unnecessary prostate biopsies. Thus, emphasis has...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncotarget 2018-04, Vol.9 (32), p.22359-22367
Hauptverfasser:	Levin, Rachel A, Lund, Maria E, Truong, Quach, Wu, Angela, Shore, Neal D, Saltzstein, Daniel R, Concepcion, Raoul S, Paivanas, Thomas A, van Breda, Arletta, Beebe-Dimmer, Jennifer, Ruterbusch, Julie J, Wissmueller, Sandra, Campbell, Douglas H, Walsh, Bradley J
Format:	Artikel
Sprache:	eng
Schlagworte:	Research Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!